Advertisement
U.S. markets closed
  • S&P Futures

    5,304.25
    -4.00 (-0.08%)
     
  • Dow Futures

    40,140.00
    -36.00 (-0.09%)
     
  • Nasdaq Futures

    18,465.00
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,145.20
    +6.80 (+0.32%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0779
    -0.0014 (-0.13%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2621
    -0.0001 (-0.01%)
     
  • USD/JPY

    151.2820
    -0.0900 (-0.06%)
     
  • Bitcoin USD

    70,779.53
    +1,274.58 (+1.83%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,412.30
    +244.23 (+0.61%)
     

Concert Pharmaceuticals (CNCE) Catches Eye: Stock Up 9.3%

Concert Pharmaceuticals, Inc. (CNCE) was a big mover last session with its shares rising over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company since March 24, as the stock is now trading above the volatile price range of $11.69 to $13.41.
This biotechnology company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate has also remained unchanged over the same period. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Concert Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked Med-Drug stocks include Lannett Company, Inc. (LCI), Questcor Pharmaceuticals, Inc. (QCOR) and Shire plc (SHPG). All the three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




CONCERT PHARMACEUTICALS INC (CNCE): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report

QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report

SHIRE PLC ADS (SHPG): Free Stock Analysis Report


Zacks Investment Research

Advertisement